First Generic Version of COPD Inhaler Advair Diskus Approved by FDA
News
The first generic version of the inhalation treatment Advair Diskus (fluticasone/salmeterol powder) was recently approved by the U.S. Food and Drug Administration for chronic obstructive pulmonary disease (COPD) and asthma patients. ... Read more